[HTML][HTML] Channelopathies of skeletal muscle excitability

SC Cannon - Comprehensive Physiology, 2015 - ncbi.nlm.nih.gov
Familial disorders of skeletal muscle excitability were initially described early in the last
century and are now known to be caused by mutations of voltage-gated ion channels. The …

Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery

P Imbrici, A Liantonio, GM Camerino… - Frontiers in …, 2016 - frontiersin.org
In the human genome more than 400 genes encode ion channels, which are
transmembrane proteins mediating ion fluxes across membranes. Being expressed in all …

Molecular diagnostic experience of whole-exome sequencing in adult patients

JE Posey, JA Rosenfeld, RA James, M Bainbridge… - Genetics in …, 2016 - nature.com
Purpose: Whole-exome sequencing (WES) is increasingly used as a diagnostic tool in
medicine, but prior reports focus on predominantly pediatric cohorts with neurologic or …

Effect of mexiletine on muscle stiffness in patients with nondystrophic myotonia evaluated using aggregated N-of-1 trials

BC Stunnenberg, J Raaphorst, HM Groenewoud… - Jama, 2018 - jamanetwork.com
Importance In rare diseases it is difficult to achieve high-quality evidence of treatment
efficacy because of small cohorts and clinical heterogeneity. With emerging treatments for …

Guidelines on clinical presentation and management of nondystrophic myotonias

BC Stunnenberg, S LoRusso, WD Arnold… - Muscle & …, 2020 - Wiley Online Library
The nondystrophic myotonias are rare muscle hyperexcitability disorders caused by gain‐of‐
function mutations in the SCN4A gene or loss‐of‐function mutations in the CLCN1 gene …

Genetic neurological channelopathies: molecular genetics and clinical phenotypes

J Spillane, DM Kullmann, MG Hanna - Journal of Neurology …, 2016 - jnnp.bmj.com
Evidence accumulated over recent years has shown that genetic neurological
channelopathies can cause many different neurological diseases. Presentations relating to …

[HTML][HTML] Dysfunction of NaV1. 4, a skeletal muscle voltage-gated sodium channel, in sudden infant death syndrome: a case-control study

R Männikkö, L Wong, DJ Tester, MG Thor, R Sud… - The Lancet, 2018 - thelancet.com
Background Sudden infant death syndrome (SIDS) is the leading cause of post-neonatal
infant death in high-income countries. Central respiratory system dysfunction seems to …

Mexiletine in myotonic dystrophy type 1: a randomized, double-blind, placebo-controlled trial

C Heatwole, E Luebbe, S Rosero, K Eichinger… - Neurology, 2021 - AAN Enterprises
Objective To assess mexiletine's long-term safety and effect on 6-minute walk distance in a
well-defined cohort of patients with myotonic dystrophy type 1 (DM1). Methods We …

Non-dystrophic myotonia: prospective study of objective and patient reported outcomes

JR Trivedi, B Bundy, J Statland, M Salajegheh… - Brain, 2013 - academic.oup.com
Non-dystrophic myotonias are rare diseases caused by mutations in skeletal muscle
chloride and sodium ion channels with considerable phenotypic overlap between diseases …

[HTML][HTML] Establishment of an international collaborative network for N-of-1 trials and single-case designs

J Nikles, P Onghena, JWS Vlaeyen, RK Wicksell… - Contemporary clinical …, 2021 - Elsevier
In this article we briefly examine the unique features of Single-Case Designs (SCDs)(studies
in a single participant), their history and current trends, and real-world clinical applications …